Nalaganje...
Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma
Background: Wixela(®) Inhub(®) is a dry powder inhaler approved as a generic equivalent to Advair(®) Diskus(®) (fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients with asthma or chronic obstructive pulmonary disease (COPD). This study aimed at confirming the local (lung) the...
Shranjeno v:
| izdano v: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Mary Ann Liebert, Inc., publishers
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7133441/ https://ncbi.nlm.nih.gov/pubmed/31634023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2019.1547 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|